SAA1 and cytomegalovirus infection: Only 23.6% of the patients in the HLA-haploidentical group and 14.7% of the patients in the HLA-identical group developed CMV infections; these rates were significantly lower than those in another SAA HLA-haploidentical HSCT study without the use of timely IVIG34.